Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationThe European Commission (EC) have adopted the revised Annex VI to Regulation (EU) No 536/2014 (Clinical Trials Regulation, CTR)
EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022
The latest edition of the Veterinary Medicines Regulation Highlights.
EMA and the Heads of Medicines Agencies (HMA) have issued a joint statement confirming that biosimilar medicines approved in the European Union (EU) are interchangeable with their reference medicine or with an equivalent biosimilar.
FDA have published an Excel sheet of answers to some GCP questions.
MHRA have updated the CAPA guidance PDF on 27th September.
Publication of revised PIC/S Annex 1 The revised Annex 1 to the PIC/S GMP Guide on the manufacture of sterile products has been published and will enter into force on 25 August 2023, except for point 8.123 which is postponed until 25 August 2024. The date of entry into operation is aligned with that of the revised EU Annex 1, which is identical to PIC/S Annex 1 (with some very minor editorial differences).
EDQM - Call for experts: join the Ph. Eur. network
EMA - Event Summary on Workshop on the guidance on the protection of personal data and commercially confidential information (CCI) in documents submitted or uploaded via CTIS
EMA - Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 September 2022